Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00946296 · ClinicalTrials.gov registry record · Phase 4
Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease
A Phase 4 study, sponsored by University of Massachusetts, Worcester.
- Completed
- Registry status
- Phase 4
- Development phase
- 36
- Enrollment target
NCT00946296 is a Phase 4 study that has completed, run by University of Massachusetts, Worcester. The registered enrollment target is 36 participants.
The verdict
NCT00946296, a Phase 4 study, has completed, sponsored by University of Massachusetts, Worcester.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 36 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether a brief course of SSKI (saturated solution of potassium iodide) administered preoperatively provides any benefit in the surgical management of patients undergoing thyroidectomy as definitive management of their Graves Disease.
Interventions
- DRUG Potassium Iodide
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 36 participants |
| Start Date | 2005-04 |
| Est. Completion | 2013-04 |
| Phase | Phase 4 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00946296
The ClinicalTrials.gov registry entry for NCT00946296 describes a study currently listed as completed, categorized as Phase 4. The registered enrollment target is 36 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Massachusetts, Worcester, which has 240 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Potassium Iodide is the first listed.
NCT00946296 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00946296 about?
NCT00946296 is a clinical study titled "Impact of SSKI Pre-Treatment on Blood Loss in Thyroidectomy for Graves Disease". The purpose of this study is to determine whether a brief course of SSKI (saturated solution of potassium iodide) administered preoperatively provides any benefit in the surgical management of patients undergoing thyroidectomy as definitive management of their Graves Disease.
What is the current status of trial NCT00946296?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 36 participants. The study started on 2005-04. Estimated completion is 2013-04.
What interventions are being tested in trial NCT00946296?
The interventions under investigation include: Potassium Iodide (DRUG).
Who is sponsoring clinical trial NCT00946296?
This trial is sponsored by University of Massachusetts, Worcester, which has 240 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.